You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable Gallbladder Neoplasms

Showing 1 - 25 of 5,576
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gallbladder Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)

Completed
  • Gallbladder Neoplasms
  • Irreversible electroporation (IRE)
  • NanoKnife
  • Guangzhou, Guangdong, China
    Biological treatment center in Fuda cancer hospital
Sep 1, 2021

Unresectable Gallbladder Cancer Trial in Guangzhou (Carrilizumab plus GEMOX)

Not yet recruiting
  • Unresectable Gallbladder Cancer
  • Carrilizumab plus GEMOX
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 16, 2023

Deep Learning Radiogenomics For Individualized Therapy in

Recruiting
  • Gallbladder Cancer
  • CT scan
  • Chandigarh, Punjab, India
    Post Graduate Institute of Medical Education and Research
Feb 6, 2023

Gallbladder Cancer, Initially Unresectable, the First Line Treatment Trial in Shanghai (Combination of Gemcitabine,

Recruiting
  • Gallbladder Cancer
  • +2 more
  • Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 24, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Gallbladder Cancer Unresectable Trial in Lucknow (chemoradiation)

Recruiting
  • Gallbladder Cancer Unresectable
  • chemoradiation
  • Lucknow, Uttar Pradesh, India
    Sanjay Gandhi Postgraduate Institute of Medical Sciences
Aug 6, 2022

Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

Active, not recruiting
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • +27 more
  • Los Angeles, California
  • +2 more
Aug 5, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • (no location specified)
Aug 16, 2022

Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Stage III Gallbladder Cancer AJCC v7 Trial in Houston

Completed
  • Cholangiocarcinoma
  • +11 more
  • Laboratory Biomarker Analysis
  • Ramucirumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 7, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • (no location specified)
Nov 8, 2022

Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7

Completed
Has Results
  • Stage III Intrahepatic Cholangiocarcinoma AJCC v7
  • +8 more
  • Scottsdale, Arizona
  • +2 more
Jan 5, 2022

Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial

Recruiting
  • Metastatic Distal Bile Duct Adenocarcinoma
  • +9 more
  • Atezolizumab
  • +6 more
  • Phoenix, Arizona
  • +28 more
Dec 31, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy

Enrolling by invitation
  • Gallbladder Cancer
  • Minimally invasive surgery
  • Barcelona, Spain
    Hospital del Mar
Sep 25, 2023

Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)

Recruiting
  • Gallbladder Cancer
  • Everolimus 10 mg
  • Standard of care
  • Varanasi, UP, India
    Banaras Hindu University
Apr 18, 2023

Stage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8, Stage IIB Gallbladder Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Stage II Gallbladder Cancer AJCC v8
  • +5 more
  • Atlanta, Georgia
    Emory University, Winship Cancer Institute
Jan 3, 2023

Gallbladder Cancer Trial (Envafolimab+Gemox)

Not yet recruiting
  • Gallbladder Cancer
  • (no location specified)
Aug 25, 2023

A Case Series on Incidentally Detected Gallbladder Malignancy

Completed
  • Gallbladder Malignant Neoplasm
  • Cholecystectomy, extended cholecystectomy
  • Hyderabad, Telangana, India
    Osmania General Hospital
Nov 2, 2022

Gallbladder Carcinoma Trial in Shanghai (gemcitabine and oxaliplatin., Afatinib)

Recruiting
  • Gallbladder Carcinoma
  • Shanghai, Shanghai, China
  • +1 more
Dec 21, 2022

Poorly Differentiated Adenocarcinoma With Signet Ring Cells of

Completed
  • Gallbladder Cancer
  • laparoscopic whole-layer cholecystectomy
  • Ōita, Oita, Japan
    oita Red Cross hospital
Sep 24, 2022

Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer Trial in Tianjin

Recruiting
  • Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 16, 2022

Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

Active, not recruiting
  • Cholangiocarcinoma
  • +3 more
  • Durvalumab
  • +3 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Oct 14, 2021

Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical

Recruiting
  • Incidental Gallbladder Carcinoma
  • Biliary Tract Cancer
  • Frankfurt, Germany
    Krankenhaus Nordwest gGmbH
Sep 7, 2022

Hepatic Carcinoma Trial in Guangzhou (NanoKnife)

Completed
  • Hepatic Carcinoma
  • NanoKnife
  • Guangzhou, Guangdong, China
    中国
Sep 1, 2021